| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) (NCT02742675) | Fudan University | 2015-09-01 |
| Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer (NCT02570919) | Fundacao Champalimaud | 2015-09-01 |
| Safety Study of MGD009 in B7-H3-expressing Tumors (NCT02628535) | MacroGenics | 2015-09-01 |
| Lung Protective Ventilation During Robotic Assisted Prostatectomy (NCT02551341) | Jørgen Bjerggaard Jensen | 2015-09-01 |
| Prospective Prolaris Value and Efficacy (NCT03152448) | Myriad Genetic Laboratories, Inc. | 2015-09-01 |
| Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors (NCT02600156) | Mayo Clinic | 2015-09-01 |
| Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad) (NCT04110782) | Azienda Policlinico Umberto I | 2015-09-01 |
| Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation. (NCT02739048) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2015-09-01 |
| Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA (NCT02989623) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-09-01 |
| Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population (NCT02518698) | Bayer | 2015-08-31 |
| A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF (NCT02411786) | University of Wisconsin, Madison | 2015-08-24 |
| A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine (NCT02485964) | University of Arkansas | 2015-08-01 |
| Effect of Dexmedetomidine on Heart-rate Corrected QT(QTc) Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial- (NCT02536014) | Yonsei University | 2015-08-01 |
| Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation (NCT02512120) | Korea University Anam Hospital | 2015-08-01 |
| Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer (NCT02555397) | Henry Ford Health System | 2015-08-01 |
| Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study) (NCT02507427) | Seoul National University Hospital | 2015-07-26 |
| Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 (NCT02981797) | H. Lee Moffitt Cancer Center and Research Institute | 2015-07-22 |
| Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer (NCT02477137) | Karolinska Institutet | 2015-07-20 |
| Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer (NCT02362451) | National Cancer Institute (NCI) | 2015-07-10 |
| Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing (NCT02353715) | Duke University | 2015-07-07 |
| Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning (NCT02470910) | Dana-Farber Cancer Institute | 2015-07-01 |
| Assessment of Prostate MRI Before Prostate Biopsies (NCT02485379) | Hospices Civils de Lyon | 2015-07-01 |
| Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis (NCT02457715) | Duke University | 2015-07-01 |
| Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness (NCT02545881) | Turku University Hospital | 2015-07-01 |
| Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy (NCT03321149) | University of Illinois at Urbana-Champaign | 2015-07-01 |
| J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts (NCT02552394) | Weill Medical College of Cornell University | 2015-07-01 |
| Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer (NCT02654938) | Panacela Labs LLC | 2015-07-01 |
| Metformin And Longevity (NCT02511665) | Guy's and St Thomas' NHS Foundation Trust | 2015-07-01 |
| Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer (NCT02499848) | Sophiris Bio Corp | 2015-07-01 |
| Measuring the Effect of Radiation Therapy on Patient Activity Levels (NCT02694380) | University of Pittsburgh | 2015-07-01 |
| Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer (NCT02468284) | Ferring Pharmaceuticals | 2015-07-01 |
| Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer (NCT02514213) | Inovio Pharmaceuticals | 2015-07-01 |
| Prostate Cancer E-Health-Tutorial (NCT02503748) | Zurich University of Applied Sciences | 2015-07-01 |
| Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled Trial (NCT01762956) | University of Sao Paulo | 2015-07-01 |
| Cancer Diagnosis by Multiparametric UltraSound of the Prostate (NCT02712684) | University College, London | 2015-07-01 |
| Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues (NCT02542501) | Ipsen | 2015-07-01 |
| Towards Optimal Prescription of Chemotherapy in Prostate Cancer (NCT02512185) | University Health Network, Toronto | 2015-07-01 |
| Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer (NCT02481648) | Vancouver Prostate Centre | 2015-07-01 |
| Physical Therapy for Men Undergoing Prostatectomy (NCT02558946) | Indiana University | 2015-06-29 |
| HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer (NCT03424694) | CR-CSSS Champlain-Charles-Le Moyne | 2015-06-22 |
| DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy (NCT02663817) | University of Miami | 2015-06-19 |
| Quantitative Prostate Cancer Contrast-enhanced Ultrasound (NCT02295449) | Hospices Civils de Lyon | 2015-06-09 |
| ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT02325557) | Advaxis, Inc. | 2015-06-04 |
| Radium-223 in Combination With Enzalutamide (NCT02225704) | Cancer Trials Ireland | 2015-06-03 |
| Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer (NCT02430480) | National Cancer Institute (NCI) | 2015-06-03 |
| Carbon-11 Labeled Sarcosine in Prostate Cancer (NCT02462447) | University of Michigan | 2015-06-01 |
| Ipilimumab and GMCSF Immunotherapy for Prostate Cancer (NCT01530984) | Lawrence Fong | 2015-06-01 |
| Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital Behavior (NCT03692585) | Danish Cancer Society | 2015-06-01 |
| Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer (NCT01835977) | Clinical Research Office of the Endourological Society | 2015-06-01 |
| A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC (NCT02438007) | LTN PHARMACEUTICALS, INC. | 2015-06-01 |
| Vaccination in Prostate Cancer (VANCE) (NCT02390063) | University of Oxford | 2015-06-01 |
| Linear Source Registry for Prostate Cancer (NCT02516709) | CivaTech Oncology | 2015-06-01 |
| Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8 (NCT02470936) | University of California, San Francisco | 2015-06-01 |
| Evaluation of Clarity Ultrasound Guidance for Prostate Therapy (NCT02388308) | Institute of Cancer Research, United Kingdom | 2015-05-15 |
| Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY (NCT02269982) | Duke University | 2015-05-14 |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 (NCT02362464) | National Cancer Institute (NCI) | 2015-05-12 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. (NCT02445976) | Innocrin Pharmaceutical | 2015-05-01 |
| Prospective RCT on Post Prostatectomy Urine Leak (NCT02367404) | Institut Mutualiste Montsouris | 2015-05-01 |
| Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases (NCT02454543) | Martini-Klinik am UKE GmbH | 2015-05-01 |
| Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer (NCT02423928) | Alden Cancer Therapy II | 2015-05-01 |
| Effectiveness of Community-based Football in Prostate Cancer (NCT02430792) | Rigshospitalet, Denmark | 2015-05-01 |
| Development of a Therapeutic Education Program for Patients Operated for Prostate Cancer (NCT02379260) | Institut de Cancérologie de la Loire | 2015-05-01 |
| Pillars4Life Trial (NCT02465892) | Duke University | 2015-05-01 |
| 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer (NCT02282137) | Ebrahim Delpassand | 2015-05-01 |
| Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography (NCT02437539) | Rigshospitalet, Denmark | 2015-05-01 |
| Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer (NCT02409212) | Sheffield Teaching Hospitals NHS Foundation Trust | 2015-05-01 |
| Transperineal, MRI-guided, Prostate Biopsy (NCT02651948) | University Hospital, Strasbourg, France | 2015-05-01 |
| PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer (NCT02483884) | Lantheus Biosciences Ltd. | 2015-05-01 |
| Micro RNAs to Predict Response to Androgen Deprivation Therapy (NCT02366494) | Medical College of Wisconsin | 2015-04-29 |
| Optimizing Veteran-Centered Prostate Cancer Survivorship Care (NCT01900561) | VA Office of Research and Development | 2015-04-17 |
| A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer (NCT02391480) | AbbVie | 2015-04-14 |
| Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer (NCT02415621) | H. Lee Moffitt Cancer Center and Research Institute | 2015-04-13 |
| 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer (NCT02397408) | University of California, San Francisco | 2015-04-09 |
| Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS (NCT01766869) | University of Maryland, Baltimore | 2015-04-01 |
| MRI and Biomarkers in Prostate Cancer (NCT02241122) | Turku University Hospital | 2015-04-01 |
| Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy (NCT03238066) | University of Erlangen-Nürnberg Medical School | 2015-04-01 |
| A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer (NCT02346526) | Massachusetts General Hospital | 2015-04-01 |
| Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE) (NCT02425592) | Yale University | 2015-04-01 |
| Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer (NCT02441894) | Sanofi | 2015-04-01 |
| Comparison Between Conventional and Model-based Infusion Strategy of IV PCA in Patients Undergoing RALP (NCT02402621) | Asan Medical Center | 2015-04-01 |
| Relationship of Mitochondrial Enzymes With Cancer Related Fatigue (NCT02414971) | University of Florida | 2015-04-01 |
| Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer (NCT02459912) | NYU Langone Health | 2015-04-01 |
| Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy (NCT02408497) | National Cancer Centre, Singapore | 2015-04-01 |
| Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy (NCT02432820) | Stanford University | 2015-04-01 |
| Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) (NCT02380274) | Astellas Pharma Global Development, Inc. | 2015-03-27 |
| Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model (NCT02451345) | University of California, San Francisco | 2015-03-25 |
| Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY (NCT04307056) | Association Francaise d'Urologie | 2015-03-23 |
| The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment (NCT02543905) | Institute of Cancer Research, United Kingdom | 2015-03-09 |
| Focal Prostate Radiofrequency Ablation (NCT02294903) | Trod Medical N.V. | 2015-03-01 |
| A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer (NCT02424513) | ImaginAb, Inc. | 2015-03-01 |
| Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention (NCT02375776) | Massachusetts General Hospital | 2015-03-01 |
| Prostate Magnetic Resonance Imaging in Patient With Previous Negative Biopsies (NCT02388126) | Turku University Hospital | 2015-03-01 |
| Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention (NCT02426216) | National Taiwan University Hospital | 2015-03-01 |
| Physical Training and Cancer-a Multicenter Clinical Trial (NCT02473003) | Uppsala University | 2015-03-01 |
| Staple vs. Suture in Robotic Prostatectomy (NCT03480074) | Swedish Medical Center | 2015-03-01 |
| A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer (NCT02396368) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-01 |
| Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life (NCT02333435) | CHU de Quebec-Universite Laval | 2015-02-12 |
| Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer (NCT03862170) | CR-CSSS Champlain-Charles-Le Moyne | 2015-02-10 |
| Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy (NCT02307058) | University of Miami | 2015-02-05 |